ReviewMolecules (Basel, Switzerland)2025
Gemini Surfactants: Advances in Applications and Prospects for the Future.
Review in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Preliminary Evaluation of Gemini-Surfactant-Based Formulations for Antifungal Seed Treatment in Wheat.Molecules (Basel, Switzerland) · 2026Article
- Self-assembled nanonetworks of highly stable gemini surfactant-like peptides: antibacterial mechanisms, self-assembly characteristics, and in vivo anti-infection potential.Journal of nanobiotechnology · 2026Article
- Eco-friendly and sustainable gemini ionic liquid surfactants derived from coffee waste: design, surface activity, oil spill treatment, and antimicrobial performance.RSC advances · 2026Article
- Study on the Dual Enhancement Effect of Nanoparticle-Surfactant Composite Systems on Oil Recovery Rates.Nanomaterials (Basel, Switzerland) · 2026Article
- Cationic Gemini Surfactants in the Oil Industry: Applications in Extraction, Transportation and Refinery Products.Molecules (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cationic gemini surfactants, which constitute a unique class of amphiphilic molecules composed of two hydrophilic ammonium groups and two hydrocarbon tails connected by a spacer, have emerged as highly versatile functional agents with superior interfacial activity and self-assembly behavior compared to conventional monomeric analogs. Their structural tunability enables precise control over physicochemical properties, making them attractive for applications across diverse scientific and industrial domains. In biomedical sciences, gemini surfactants act as potent antimicrobial and anti-biofilm agents, as well as efficient carriers for drug and gene delivery. In nanotechnology and optoelectronics, they facilitate the synthesis and stabilization of nanoparticles, quantum dots, and perovskite nanocrystals, leading to improved colloidal stability, enhanced photophysical performance, and extended material lifetimes. Within the petroleum industry, gemini surfactants have proven effective in enhanced oil recovery (EOR) by reducing interfacial tension and in crude oil transportation as drag-reducing agents (DRAs), significantly lowering viscosity, turbulence, and pipeline energy losses. This review summarizes recent advances in the chemistry, mechanisms of action, and applications of gemini surfactants, highlighting their multifunctionality and emphasizing their potential in the development of next-generation sustainable technologies.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.